Advances in vaccine and treatment research open new doors in the fight against HIV

Researchers announced encouraging developments across several critical areas of HIV research at an official press conference at the 9th IAS Conference on HIV Science (IAS 2017) today.

These included a promising vaccine candidate, positive results for an innovative HIV treatment option and better strategies to combat co-infections. The briefing also featured the results of a rigorous new survey in Swaziland – which has the world’s highest HIV prevalence – showing the extraordinary national impact of expanded HIV prevention and treatment efforts.

“Each of the studies we are highlighting today takes us one step closer to the end of HIV,” Linda-Gail Bekker, the International AIDS Society (IAS) President and International Scientific Chair of IAS 2017, said.

“This research moves us forward on many fronts, from vaccines to new treatment approaches, to real-world evidence that our current efforts to expand testing and treatment are paying off.”

The press briefing highlighted five studies, which were selected from more than 1,700 scientific abstracts being presented at IAS 2017.

PROMISING HIV VACCINE REGIMEN CLEARED FOR NEW EFFICACY STUDY

Results from APPROACH, a Phase 1/2a study evaluating seven different “prime boost” HIV vaccine regimens, identified a promising vaccine candidate that will be evaluated in a proof-of-concept efficacy study among those at risk for HIV. The APPROACH study included 393 low-risk, HIV-negative adults in the United States, Rwanda, Uganda, South Africa and Thailand.

Dan Barouch of Harvard Medical School reported the APPROACH study results, which found that the vaccine regimen encompassing two primes with Ad26.Mos.HIV and two boosts with Ad26.Mos.HIV and aluminum-adjuvanted Clade C gp140 achieved the strongest immunological response. This same regime also provided the greatest protection in earlier non-human primate studies. The proof-of-concept study could start by the end of 2017.

Tareq Salahuddin

Dr. Tareq Salahuddin is an award-winning journalist and a Special Correspondent of News Hour. He is a Public Health Professional working in the development sector. Dr. Tareq, a medical graduate, is a member of Public Health Association of Bangladesh and a former member of the Governing Council and Policy Committee of the World Federation of Public Health Associations (WFPHA), a J2J Fellow on HIV/AIDS and a member of the International AIDS Society. To know more about Dr. Tareq, please visit his personal website (www.tareqsalahuddin.net) or simply Google his name.
No Comments

Join Epidemiology Congress 2019

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
Banglalink and Facebook jointly launched the campaign "Learn More, be More"
SRK as Satyajit Ray! Here is the truth behind the poster
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
Huawei introduces EMI facilities for smartphone purchase in Bangladesh
World Heart Day rally organized in Guwahati

Advertisement

News of the Month

Scroll Up
%d bloggers like this: